ELAN - CIK 0001739104
Elanco Animal Health Inc (ELAN) reported revenue of $4.71B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $4.71B | +6.2% |
| FY 2024 | $4.44B | +0.5% |
| FY 2023 | $4.42B | +0.1% |
| FY 2022 | $4.41B | -7.4% |
| FY 2021 | $4.76B | +45.6% |
| FY 2020 | $3.27B | +6.6% |
| FY 2019 | $3.07B | +0.1% |
| FY 2018 | $3.07B | +6.2% |
| FY 2017 |
Elanco Animal Health Inc (ELAN) reported revenue of $4.71B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Elanco Animal Health Inc's revenue grew from $2.91B to $4.71B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.89B |
| -0.8% |
| FY 2016 | $2.91B | - |